Literature DB >> 34326012

Fructose and fructose kinase in cancer and other pathologies.

Hongfei Jiang1, Qian Lin1, Leina Ma1, Shudi Luo2, Xiaoming Jiang2, Jing Fang3, Zhimin Lu4.   

Abstract

Fructose metabolism and fructose kinase KHK-C/A are key factors in the development of lipid oversynthesis-promoted metabolic disorders and cancer. Here, we summarize and discuss the current knowledge about the specific features of fructose metabolism and the distinct roles of KHK-C and KHK-A in metabolic liver diseases and their relevant metabolic disorders and cancer, and we highlight the specific protein kinase activity of KHK-A in tumor development. In addition, different approaches that have been used to inhibit KHK and the exploration of KHK inhibitors in clinical treatment are introduced.
Copyright © 2021 Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Fructose; Glucose; KHK-A; KHK–C; Metabolic disorders; NAFLD; NASH

Mesh:

Substances:

Year:  2021        PMID: 34326012     DOI: 10.1016/j.jgg.2021.06.006

Source DB:  PubMed          Journal:  J Genet Genomics        ISSN: 1673-8527            Impact factor:   4.275


  4 in total

Review 1.  Therapeutic RNA-silencing oligonucleotides in metabolic diseases.

Authors:  Algera Goga; Markus Stoffel
Journal:  Nat Rev Drug Discov       Date:  2022-02-24       Impact factor: 84.694

2.  Governing glutaminolysis by regulation of glutaminase succinylation.

Authors:  Qingxia Ma; Hongfei Jiang; Leina Ma; Ying Meng; Dong Guo; Yingying Tong; Zhimin Lu
Journal:  Protein Cell       Date:  2021-12-16       Impact factor: 14.870

Review 3.  Fructose metabolism and its role in pig production: A mini-review.

Authors:  Jiahao Xie; Shiyi Shi; Yucheng Liu; Shaoshuai Wang; Shahid Ali Rajput; Tongxing Song
Journal:  Front Nutr       Date:  2022-07-29

4.  A non-metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11-mediated CD133 stability.

Authors:  Juhong Wang; Fei Shao; Yannan Yang; Wei Wang; Xueying Yang; Renda Li; Hong Cheng; Sijin Sun; Xiaoli Feng; Yibo Gao; Jie He; Zhimin Lu
Journal:  Cancer Commun (Lond)       Date:  2022-08-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.